xbrl.rienks.biz

englishEnglish   nederlandsNederlands
FrancaisFrançais DeutschDeutsch 

Fornix BioSciences N.V.

AddressExchangeStocks (28-08-2008: 17:35:00)
Vijzelweg 11
8243PM Lelystad
P.O. Box 612
8200 AP Lelystad
Netherlands (The)
T +31 (0)320 267799
F +31 (0)320 256060
www.fornix.nl  
 
Exchange:AMS
Ticker:FORBI
ISIN:NL0000439990
Shares:6.803.896
FYE: 31-12
Price:9,16
Change: -6.53%
Low:9,16
High:9,31
Volume:18.829
KvK-nr: 39039138
Industry:
Health Care
Sector: Biotechnology

News

Fornix Drops After Cutting Forecast on Higher Research Spending (26 Aug)

Aug. 26 (Bloomberg) -- Fornix BioSciences NV , the maker of allergy treatments for humans and dogs, slid to the lowest value in almost five years in Amsterdam trading after cutting its profit forecast...

Helicos BioSciences to Present at Thomas Weisel Partners Healthcare Conference 2008 September 3, 2008 (27 Aug)

Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that Mr. Steve Lombardi, president and chief executive officer, will provide a company overview at the Thomas Weisel Partners Healthcare Conference 2008 on Wednesday, September 3 at 9:10 a.m. Eastern time...

Start-Up and Emerging Biotech Companies Will Tell Their Stories at Biosciences Showcase Planned for MichBio Expo (27 Aug)

MichBio, the association for Michigan's biosciences industry, announced that it has added the Michigan Biosciences Showcase to its program on day one of its 2008 Expo & Conference on November 18-19 at the Rock Financial ShowPlace Novi, MI...

Helicos BioSciences to Present at Thomas Weisel Partners Healthcare Conference 2008 September 3, 2008 (27 Aug)

CAMBRIDGE, Mass.----Helicos BioSciences Corporation announced today that Mr. Steve Lombardi, president and chief executive officer, will provide a company overview at the Thomas Weisel Partners Healthcare Conference 2008 on Wednesday, September 3 at 9:10 a.m...

Latest Stories (28 Aug)

Resonant BioSciences, LLC and Lallemand Ethanol Technology are proud to announce the introduction of PureMash ™ technology as an antibiotic free alternative for the ethanol industry...

Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry ... (25 Aug)

Neurocrine Biosciences, Inc. announced today that Kevin Gorman, President and Chief Executive Officer will be presenting at both the Thomas Weisel Healthcare Conference in Boston and the NewsMakers in the Biotech Industry Conference in New York...

Financial Calendar

Yearly resultQuaterly ResultsAnalyst & Investor Conference
16-03-2006Q1 - -
Q2 14-08-2006 -
AGMQ3 - -
-Q4 - -